Lactobacillus reuteri and bone density

What 2 graded rows on lactobacillus reuteri agree on for bone density, and where they differ. Counted side by side, never averaged.

What the rows agree on

Each block and row is one graded row from the Lactobacillus reuteri page, with its PubMed record.

Your question

Supplement
Lactobacillus reuteri Choose another

Lactobacillus reuteri and bone density

2 rows · 329 people

Split. 1 row found an improvement and 1 found no difference.

No difference
Improved
Each block is one evidence row, sized by how many people it enrolled, with its grade inside.
  • Grade C× 1
  • No effect× 1
Rows
2
Trials
2
People
329

Where they differ

From the rows
Trial sizeHow longWho was studiedWhen published

The best-graded row, grade C, is a randomized trial of 90 people (2018) and found an improvement. 1 row is graded No effect, our grade for adequately powered trials that found no effect.

The row that found no difference was larger: 239 people, against 90 people for the row that found an improvement.

The row that found no difference ran longer (2 years) than the row that found an improvement (12 months).

Only the row that found an improvement names older adults in its population.

The row that found no difference is newer (2024) than the row that found an improvement (2018).

The rows

1 improved · 1 no difference
  1. Grade CTibia volumetric bone density over 12 months · Improved

    RCT · n 90 · 2018 · Women aged 75–80 with low bone density

    10 billion CFU/day · 12 months

    Bone density loss at the tibia was smaller than with placebo (−0.83% vs −1.85%; difference about 1 percentage point). Secondary bone measures moved the same way but were not significant. Adverse events did not differ.

    Row on the Lactobacillus reuteri page · PubMed 29926979 (opens PubMed)

  2. No effectTibia volumetric bone density, hip and spine density and bone turnover over 2 years · No difference

    RCT · n 239 · 2024 · Early postmenopausal women aged 50–60 (Sweden)

    5 × 10^8 or 5 × 10^9 CFU twice daily · 2 years

    Bone density fell in all groups with no difference from placebo for either dose, and bone turnover markers did not change. No significant adverse effects.

    Row on the Lactobacillus reuteri page · PubMed 38865129 (opens PubMed)

Educational only. Not medical advice. Some links earn us a commission: kymatahealth.com/affiliate-disclosure.